(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine

C50H56F4N12O2 — CID 158214510

IUPAC(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine
SMILESCc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@@H]3c2cc(F)cc(F)c2)cnn1.Cc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@H]3c2cc(F)cc(F)c2)cnn1
InChIInChI=1S/2C25H28F2N6O/c2*1-15-7-21(12-28-30-15)32-13-16-3-4-17(14-32)22(16)11-23-29-25-24(34-6-2-5-33(25)31-23)18-8-19(26)10-20(27)9-18/h2*7-10,12,16-17,22,24H,2-6,11,13-14H2,1H3/t2*16-,17+,22?,24-/m10/s1
InChIKeyGCMDROZAXKKMEY-YMZOMTBNSA-N
MW933.07 g/mol
LogP7.74
Rot. Bonds8

About (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine

(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine (PubChem CID 158214510) has the molecular formula C50H56F4N12O2 and a molecular weight of 933.07 g/mol. Its IUPAC name is (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine.

Molecular Properties

Compound Name(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine
PubChem CID158214510
Molecular FormulaC50H56F4N12O2
Molecular Weight933.07 g/mol
Exact Mass932.46
IUPAC Name(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine
SMILESCc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@@H]3c2cc(F)cc(F)c2)cnn1.Cc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@H]3c2cc(F)cc(F)c2)cnn1
InChIInChI=1S/2C25H28F2N6O/c2*1-15-7-21(12-28-30-15)32-13-16-3-4-17(14-32)22(16)11-23-29-25-24(34-6-2-5-33(25)31-23)18-8-19(26)10-20(27)9-18/h2*7-10,12,16-17,22,24H,2-6,11,13-14H2,1H3/t2*16-,17+,22?,24-/m10/s1
InChIKeyGCMDROZAXKKMEY-YMZOMTBNSA-N
XLogP7.74
TPSA137.92 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms68
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500933.07
LogP ≤ 57.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine?
The IUPAC name of (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine (CID 158214510) is (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine.
What is the SMILES notation for (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine?
The canonical SMILES for (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine is Cc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@@H]3c2cc(F)cc(F)c2)cnn1.Cc1cc(N2C[C@H]3CC[C@@H](C2)C3Cc2nc3n(n2)CCCO[C@H]3c2cc(F)cc(F)c2)cnn1.
What is the InChIKey of (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine?
The InChIKey is GCMDROZAXKKMEY-YMZOMTBNSA-N. The full InChI is InChI=1S/2C25H28F2N6O/c2*1-15-7-21(12-28-30-15)32-13-16-3-4-17(14-32)22(16)11-23-29-25-24(34-6-2-5-33(25)31-23)18-8-19(26)10-20(27)9-18/h2*7-10,12,16-17,22,24H,2-6,11,13-14H2,1H3/t2*16-,17+,22?,24-/m10/s1.
What are the key properties of (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine?
(9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine has a molecular weight of 933.07 g/mol, XLogP of 7.74, 8 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (9R)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine;(9S)-9-(3,5-difluorophenyl)-2-[[(1S,5R)-3-(6-methylpyridazin-4-yl)-3-azabicyclo[3.2.1]octan-8-yl]methyl]-5,6,7,9-tetrahydro-[1,2,4]triazolo[5,1-c][1,4]oxazepine is sourced from PubChem (CID 158214510), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).